Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2022-06-10 2022-06-10
Drug Identification Number 02247099 02247099
Brand name ZYPREXA INTRAMUSCULAR ZYPREXA INTRAMUSCULAR
Common or Proper name Olanzapine tartrate for injection Olanzapine tartrate for injection
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients OLANZAPINE OLANZAPINE
Strength(s) 10MG 10MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 mL vial 5 mL vial
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-06-24 2022-06-24
Actual start date
Estimated end date 2022-07-07 2022-07-07
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments